Literature DB >> 465288

Interaction between levamisole and aspirin in man.

R H Rumble, P M Brooks, M S Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465288      PMCID: PMC1429667          DOI: 10.1111/j.1365-2125.1979.tb04657.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.

Authors:  G G Graham; G D Champion; R O Day; P D Paull
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

2.  Determination of acetylsalicylic acid and salicylic acid in plasma.

Authors:  M Rowland; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

3.  Immunostimulant therapy with levamisole for rheumatoid arthritis.

Authors:  E C Huskisson; J Scott; H W Balme; P A Dieppe; J Trapnell; D A Willoughby
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

4.  Application of salivary salicylate data to biopharmaceutical studies of salicylates.

Authors:  G Graham; M Rowland
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

5.  Treatment of rheumatoid arthritis with levamisole. A controlled trial.

Authors:  L A Runge; R S Pinals; S H Lourie; R H Tomar
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

6.  Rheumatoid arthritis improved by treatment with levamisole and L-histidine.

Authors: 
Journal:  Med J Aust       Date:  1976-09-04       Impact factor: 7.738

  6 in total
  3 in total

Review 1.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

2.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 3.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.